NCT01818440View on ClinicalTrials.gov

Fluoroscopy or 3-D Roadmap Imaging Software for Liver Tumor Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 21, 2013

Primary Completion Date

September 16, 2015

Study Completion Date

August 22, 2018

Conditions
Image-Guided Surgery
Interventions
OTHER

3D Roadmap software

Two scanning methods will be used by doctors to position catheters in the blood vessels to deliver the chemotherapy and close the blood supply to the tumor.

OTHER

Fluoroscopy

Patients will have the procedure performed with regular fluoroscopy (X-ray). Regular fluoroscopy is the standard method.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT01818440 - Fluoroscopy or 3-D Roadmap Imaging Software for Liver Tumor Treatment | Biotech Hunter | Biotech Hunter